Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001610717-23-000153

Chief Legal and HR Officer sold 3,750 shares at $20.85 ($78,188)

  • Chief Legal and HR Officer acquired 3,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bizily Scott · Chief Legal and HR Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-08 Exercise or conversion : show line 1 in the form +3,750 $8.04 $30,150 5,487 D
2023-06-08 Sale : show line 2 in the form −3,750 $20.85 $78,188 1,737 D
Open-market sales · 3,750 sh · avg $20.85 · $78,188

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-08 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −3,750 48,750 D
Loading xslF345X04/form4.xml…